Via Reuters
“The group’s Smiths Medical unit was providing intellectual property and advice to other companies to make its PARAPAC Plus lightweight ventilators, and it was ramping up its own production at its site in Luton, just north of London.”
“Smiths said it was also talking to contract manufacturers to add production capacity in the United States and elsewhere.”
“‘We are doing everything possible to substantially increase production of our ventilators at our Luton site and worldwide,’ its chief executive, Andrew Reynolds Smith, said.”
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via this email or other communications.
